Zeptolife
1 known investors
Zepto develops a targeted liquid biopsy platform for infectious disease diagnostics, offering plasma-based molecular testing through its CLIA reference laboratory and an integrated sample-to-result platform for use in hospital laboratories. It also provides analytical performance and reference testing support to help diagnostics obtain FDA clearance.
BiotechHealthtechMedical Devices